The global wearable patch market was valued at $12,239.7 million in 2019, and is projected to reach $27,820.5 million by 2027, registering a CAGR of 9.6% from 2020 to 2027. Moreover, high cost of ...

Like Stelo, Lingo takes the form of a patch with a tiny ... communicating glucose readings to a smartphone. While primarily aimed at diabetics, both Abbott and Dexcom believe there is an OTC ...

Abbott is already a big player in the wearable glucose-monitoring sector ... from the FDA – will take the form of a small patch-like device similar to Abbott's FreeStyle Libre 3 device (pictured ...

Medical device companies presented new data this week at the Advanced Technologies & Treatments for Diabetes conference.

Treatments for Type 2 diabetes and new clinical trial data on ... give Dexcom a CGM that can be worn for as long as competitor Abbott’s Freestyle Libre 3 Plus sensor. COO Jake Leach said in ...

Amsterdam played host to this year's edition of the International Conference on Advanced Technologies & Treatments for ...

Beta Bionics recently brought its iLet bionic pancreas to market in 2023 and completed an IPO to become a publicly-traded ...

For individuals with type 1 diabetes, low-glucose alerts improve the time below range for drivers and reduce the incidence of ...

Wearable mobile health technology could help people with type 2 diabetes (T2D) to stick to exercise regimens that help them ...

Users of Abbott’s CGM device can now view data and gain additional insights through Glooko’s diabetes management platform.

The Precision Xtra Blood Glucose & Ketone Monitoring System was designed for easy testing. Intuitive setup and simple icon-driven menus help simplify blood glucose monitoring. In addition ...

IRVINE, Calif., March 25, 2025 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today reported its financial ...